Know Cancer

or
forgot password

Assessment of the Use of Music Therapy on Nausea and Pain During Hospitalization for Autologous Stem Cell Transplantation


N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma

Thank you

Trial Information

Assessment of the Use of Music Therapy on Nausea and Pain During Hospitalization for Autologous Stem Cell Transplantation


Patients randomized to receive music therapy will receive 2 sessions of live music therapy,
at least 48 hours apart, from a Music Therapist-Board Certified (MT-BC, certified through
the Certification Board for Music Therapists) in their room. This will occur between days -1
and +5, with the first music therapy session being as close to day +1 as possible and the
second session being at least 48 hours later (but no more than 96 hours later).

Those patients randomized to standard therapy (no music therapy) are allowed to listen to
music; however they will not receive interactive music therapy from a certified therapist.
Following day +7, music therapy will be offered to all patients who are interested in
participating.

No narcotic or anti-emetic therapy will be administered for at least 2 hours prior to music
therapy sessions or to assessments. Patients will rate nausea and pain at the beginning and
end of the first music therapy session on a validated visual analog scale.12-14 The scale
will be 10cm with the least nausea or pain at point 0 and the greatest nausea or pain at
point 10. Patients will be asked to rate their nausea and pain on day +5 and day +7.


Inclusion Criteria:



- Be older than 18 years of age

- Have a diagnosis of multiple myeloma, non-Hodgkin, or Hodgkin lymphoma

- Be undergoing ASCT (Autologous Stem Cell Transplantation)

Exclusion Criteria:

- Have had previous ASCT

- Have a diagnosis of leukemia

- History of prior music therapy

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care

Outcome Measure:

Patient perception of nausea

Outcome Description:

Compare the difference in patient perception of nausea in those who receive music therapy and those who do not.

Outcome Time Frame:

7 days after intervention

Safety Issue:

No

Principal Investigator

Hien Duong, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

CASE11Z10

NCT ID:

NCT01487031

Start Date:

November 2011

Completion Date:

Related Keywords:

  • Multiple Myeloma
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Autologous Stem Cell Transplantation
  • multiple myeloma
  • non-Hodgkin
  • Hodgkin lymphoma
  • Music Therapy
  • Nausea
  • Pain
  • Hodgkin Disease
  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma
  • Neoplasms, Plasma Cell
  • Nausea

Name

Location

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio  44195